Letter: vedolizumab for the management of inflammatory bowel disease in patients after liver transplantation for primary sclerosing cholangitis.

Hartery, K; O'Reilly, S; Houlihan, D; Doherty, G; Mulcahy, H; Cullen, G; Sheridan, J

Hartery, K; O'Reilly, S; Houlihan, D; Doherty, G; Mulcahy, H; Cullen, G; Sheridan, J.

Afiliación

Hartery K; Department of Gastroenterology, Centre for Colorectal Disease, St. Vincent's University Hospital, Dublin, Ireland.
O'Reilly S; School of Medicine, University College Dublin, Dublin, Ireland.
Houlihan D; Department of Gastroenterology, Centre for Colorectal Disease, St. Vincent's University Hospital, Dublin, Ireland.
Doherty G; School of Medicine, University College Dublin, Dublin, Ireland.
Mulcahy H; School of Medicine, University College Dublin, Dublin, Ireland.
Cullen G; National Liver Unit, St. Vincent's University Hospital, Dublin, Ireland.
Sheridan J; Department of Gastroenterology, Centre for Colorectal Disease, St. Vincent's University Hospital, Dublin, Ireland.

Aliment Pharmacol Ther ; 45(2): 376-378, 2017 01.

Article en En | MEDLINE | ID: mdl-27933688

Asunto(s)

Colangitis Esclerosante; Trasplante de Hígado; Anticuerpos Monoclonales Humanizados; Humanos; Enfermedades Inflamatorias del Intestino

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Colangitis Esclerosante / Trasplante de Hígado Límite: Humans Idioma: En Revista: Aliment Pharmacol Ther Asunto de la revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2017 Tipo del documento: Article País de afiliación: Irlanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google